Advocacy Actions
Telephone Meeting with Cosmetics Europe
On 27 June, a telephone meeting with Cosmetics Europe was held for ET China activity.
Read moreComments on Anhui HSA's Draft "Implementation Plan for Centralised Purchasing of High Value Medical Consumables"
The Healthcare Equipment (HCE) Working Group submitted comments on the Anhui Healthcare Security Administration's (Anhui HSA's) draft "Implementation Plan for Centralised Purchasing of High Value Medical Consumables" in public medical institutions.
Read moreMeeting of the draft of Management Rules for Cosmetic Registration
The NMPA Cosmetics Department held a meeting on June 24 to discuss the draft of Management Rules for Cosmetic Registration .
Read moreLetter to Director General Wen Ku, Department of Information and Communication Development, Ministry of Industry and Information Technology (MIIT), on the Opening Up of Value Added Telecom Services (VATS) in Free Trade Zones in China
The European Chamber ICT Working Group sent a to Director General Wen Ku, Department of Information and Communication Development, Ministry of Industry and Information Technology (MIIT), on the plans of opening up of Value Added Telecom Services (VATS) in Free Trade Zones in China.
Read moreSubmitted comments to NDRC on Development of Circular Economy during the Fourteenth Five-Year Plan
On 30th June, the European Chamber’s Environment and Investment working groups submitted comments to the NDRC on Development of Circular Economy during the Fourteenth Five-Year Plan.
Read moreMeeting of the Call for Comments of Measures for the management of cosmetics labels
The NMPA Cosmetics Department held a meeting on June 23 to discuss the draft of Measures for the management of cosmetics labels.
Read more9th EU - China Energy Dialogue
EU- China Energy Dialogue -back to back with the EU-China Summit, led by commissioner Kadri Simson and Administrator ZHANG Jianhua
Read moreAdvocacy Letter to the NMPA and the CMDE on Consequences of the Pending Medical Device Regulation (MDR) and In-vitro Diagnostic Medical Device Regulation (IVDR) in Europe for registrations in China
On 22 June, the medical device sector sent an advocacy letter to the National Medical Products Administration and the Centre for Medical Device Evaluation on consequences of the pending Medical Device Regulation (MDR) and In-vitro Diagnostic Medical Device Regulation (IVDR) in Europe for registrations in China.
Read moreDiscussion of CSR Forum working plan with the chair and vice-chair of the CSR Forum
On 22nd June, a discussion of CSR Forum working plan with the chair and vice-chair of the CSR Forum.
Read moreComments to the NMPA on the Administrative Measures for the Filing of Pharmaceutical Representatives (Trial) (Draft for Comments)
Comments to the NMPA on the Administrative Measures for the Filing of Pharmaceutical Representatives (Trial) (Draft for Comments)
Read more